Home › Trials › NCT02071134

Registry of outcomes for the Vercise DBS System in Parkinson's disease

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Observational Boston Scientific Corporation · NCT02071134

This study is collecting information from around the world to see how well the Vercise Deep Brain Stimulation system helps people with Parkinson's disease manage their symptoms and improve their quality of life.

Quick facts

Study typeObservational
Enrollment1500 (estimated)
Ages18 Years and up
SexAll
SponsorBoston Scientific Corporation Industry-sponsored
Locations84 sites (Aliso Viejo, California and 83 other locations)
Trial IDNCT02071134 on ClinicalTrials.gov

What this trial studies

This registry aims to compile worldwide outcomes from the use of the Vercise Deep Brain Stimulation (DBS) System by Boston Scientific in treating Parkinson's disease. It evaluates the effectiveness of the system in improving disease symptoms and overall quality of life, comparing results to baseline measurements. The study also assesses the use of Image Guided Programming (IGP) and the DBS Illumina 3D feature as planning tools for patient programming. By gathering data from various locations, the registry seeks to provide a comprehensive overview of the system's performance.

Who should consider this trial

Good fit: Ideal candidates include adults aged 18 and older who meet the criteria for the Vercise System's use.

Not a fit: Patients with significant cognitive or psychiatric impairments or those who meet contraindications for the Vercise System may not benefit from this registry.

Why it matters

Potential benefit: If successful, this registry could enhance the understanding of Vercise DBS System's effectiveness, leading to improved treatment strategies for Parkinson's disease patients.

How similar studies have performed: Other studies on deep brain stimulation have shown promising results, indicating that this approach is supported by prior successful outcomes.

Eligibility criteria

Show full inclusion / exclusion criteria 
Key Inclusion Criteria:

* Meets criteria established in locally applicable Vercise System Direction for Use
* At least 18 years old

Key Exclusion Criteria:

* Meets any contraindication in the Vercise System locally applicable Directions for Use

Subjects with significant cognitive or psychiatric impairment may be excluded in the evaluation of GXT.

Where this trial is running

Aliso Viejo, California and 83 other locations

+34 more sites — see ClinicalTrials.gov for the full list.

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions Parkinson's DiseaseDeep brain stimulationParkinson's diseaseVercise
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.